Hims vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Novi overall, scoring 7.9/10 vs 7.8/10. Novi is more affordable at $133/mo vs $199/mo. Choose Hims for men who want glp-1 access from a well-known, publicly traded. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of Hims and Novi covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 46One of the largest and most recognized men's telehealth platforms in the US. In 2026 Hims signed a direct partnership with Novo Nordisk adding FDA-approved brand Wegovy (injection and pill) and Ozempic alongside their existing compounded semaglutide program.
Visit HimsNovi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | Hims | Novi |
|---|---|---|
| Our Score | 7.9/10 | 7.8/10 |
| Starting Price | $199/mo | $133/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 access from a well-known, publicly traded telehealth brand — now with FDA-approved brand access via the 2026 Novo Nordisk partnership | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Ranking | #12 | #14 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Polished app and web experience — one of the best user interfaces in men's telehealth
Cons
- −Brand-name pricing jumps to $599/mo for Wegovy injection — not competitive with LillyDirect/NovoCare cash prices
- −Generic support experience — large patient volume means less personalized attention
- −'Hims Oral Kit' is NOT a GLP-1 (it's a non-GLP-1 combo: metformin + bupropion + topiramate + B12 + naltrexone) — easy to confuse with their compounded semaglutide program
- −Higher price than compounded-only competitors like TrimRx or Enhance MD for the same compounded product
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
Hims edges out Novi with a score of 7.9/10 vs 7.8/10. If budget is your priority, Novi starts at $133/mo compared to Hims's $199/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand — now with fda-approved brand access via the 2026 novo nordisk partnership. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.